Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Muhammad Shipa"'
Publikováno v:
Revista Portuguesa de Nefrologia e Hipertensão, Vol 36, Iss 3, Pp 127-129 (2022)
Externí odkaz:
https://doaj.org/article/26cd880b2e0e4e96a357d82075ee6303
Autor:
Naina McCann, Raj Amarnani, Muhammad Shipa, Saad Ahmed, Fathima Thaahira Mohideen, Stefan Vöö, Jessica J. Manson
Publikováno v:
Clinical Infection in Practice, Vol 9, Iss , Pp 100060- (2021)
Background: Haemophagocytic lymphohistiocytosis (HLH) is a severe, life-threatening syndrome characterised by hyperinflammation and macrophage activation. Viral infections such as Epstein-Barr virus (EBV) are a well-recognised trigger of HLH but the
Externí odkaz:
https://doaj.org/article/ca0aaf7d50ae4382b22e274e13f92d91
Autor:
Muhammad Shipa, Liliana R Santos, Dao X Nguyen, Andrew Embleton-Thirsk, Mariea Parvaz, Lauren L Heptinstall, Ruth J Pepper, David A Isenberg, Caroline Gordon, Michael R Ehrenstein
Publikováno v:
The Lancet Rheumatology. 5:e24-e35
Autor:
Michael R. Ehrenstein, Muhammad Shipa
Publikováno v:
Journal of Experimental Medicine. 220
In this Viewpoint we discuss how experimental medicine applied in the setting of clinical trials can address unmet need in the prototypic autoimmune disease systemic lupus erythematosus (SLE) to improve outcomes for patients.
Publikováno v:
Rheumatology. 62
Background/Aims The role of highly differentiated T effector memory re-expressing CD45RA (Temra) in rheumatoid arthritis (RA) is unclear, including whether they can be used as a marker of persistent disease activity. Our aim was to investigate whethe
Autor:
Patrick Muller, Andrew Embleton-Thirsk, Kashfia Chowdhury, Beat-Lupus Investigators, Michael R. Ehrenstein, Mariea Parvaz, Caroline Gordon, David A. Isenberg, Muhammad Shipa, Liliana R Santos, Caroline J Doré
Publikováno v:
Annals of Internal Medicine. 174:1647-1657
BACKGROUND B-cell depletion with rituximab is commonly used for patients with systemic lupus erythematosus (SLE) that is refractory to conventional therapy, but it yields variable responses. We hypothesized that high B-cell activating factor (BAFF) l
Publikováno v:
Rheumatology. 61
Background/Aims Few long-term drug survival analyses have been reported for patients with rheumatoid arthritis (RA) treated with abatacept. Here we report a machine learning approach to investigate drug-survival of abatacept over 5 years in RA patien
Publikováno v:
Mediterranean Journal of Rheumatology
Mediterranean Journal of Rheumatology, Vol 30, Iss 4, Pp 220-223 (2019)
Mediterranean Journal of Rheumatology, Vol 30, Iss 4, Pp 220-223 (2019)
A 52-year-old woman known to have anti-synthetase syndrome (ASS) with positive anti-alanyl-tRNA synthetase antibody (anti-PL 12) for 4 years presented with headache and progressive deterioration of cognitive functions manifested predominantly by epis
Publikováno v:
Rheumatology (Oxford, England)
Background/Aims Rheumatologists are facing a significant challenge in the management of early rheumatoid arthritis (RA) due to limitations placed on outpatient visits during the COVID-19 pandemic. Frequent clinical assessments of disease activity are
Autor:
Fathima Thaahira Mohideen, Saad Ahmed, Stefan Vöö, Muhammad Shipa, Naina McCann, Jessica J Manson, Raj Amarnani
Publikováno v:
Clinical Infection in Practice, Vol 9, Iss, Pp 100060-(2021)
Background Haemophagocytic lymphohistiocytosis (HLH) is a severe, life-threatening syndrome characterised by hyperinflammation and macrophage activation. Viral infections such as Epstein-Barr virus (EBV) are a well-recognised trigger of HLH but the t